Klinger Shannon Thyme
Klinger Shannon Thyme, CLO, reported a transaction classified as exercise at Moderna, Inc. involving 3471.000000 shares for an estimated $0.00. Reported holdings after the transaction were 34716.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- Sep 01, 2026
- Filing date
- Sep 03, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
MRNA price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001682852-26-000167 Stock Option (Right to Buy)
- Transaction date
- Sep 01, 2026 Filed Sep 03, 2026, 08:56 PM · 2d delay
- Shares
- 3,471 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 34,716 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-16 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Legal Officer
- F1
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 9, 2025.
- F2
Restricted stock units convert into common stock on a one-for-one basis.
- F3
Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
- F4
25% of this option vested and became exercisable on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
- F5
25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
0 other transactions
0 recent txs